FDA 483 data is just the tip of the iceberg
AboutBlogFDA EmployeeOver 40,000+ FDA inspection documents: 483s, EIRs, 483Rs

483 Celltex Therapeutics, Apr 2012

$179 - Available for instant download

FDA investigators audited the Celltex Therapeutics - Sugar Land , TX, United States facility and issued inspectional observation (via FDA 483) on 27 Apr 2012.

Product Details

  • Inspection end: 27 Apr 2012
  • Location: Sugar Land, United States
  • FEI: 3009499974
Celltex Therapeutics FDA inspection 483 Apr 2012